Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
#
NCTID/Status
Study
Last Changed
315751
NCT00003541
Completed
Completed
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
Conditions: Lymphoma
Intervention: Filgrastim, CHOP Regimen, Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Prednisone, Vincristine Sulfate, Peripheral Blood Stem Cell Transplantation, Radiation Therapy
Conditions: Lymphoma
Intervention: Filgrastim, CHOP Regimen, Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Ifosfamide, Prednisone, Vincristine Sulfate, Peripheral Blood Stem Cell Transplantation, Radiation Therapy
June 20, 2013
315752
NCT00003418
Unknown status
Unknown status
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Conditions: Breast Cancer
Intervention: Exemestane, Tamoxifen Citrate
Conditions: Breast Cancer
Intervention: Exemestane, Tamoxifen Citrate
December 18, 2013
315753
NCT00003364
Completed
Completed
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Intervention: Cisplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Vincristine Sulfate, Radiation Therapy
Conditions: Lung Cancer
Intervention: Cisplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Vincristine Sulfate, Radiation Therapy
December 18, 2013
315754
NCT00003298
Completed
Completed
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
Conditions: Gastric Cancer
Intervention: Cisplatin, Fluorouracil, Leucovorin Calcium, Paclitaxel, Surgery, Radiation Therapy
Conditions: Gastric Cancer
Intervention: Cisplatin, Fluorouracil, Leucovorin Calcium, Paclitaxel, Surgery, Radiation Therapy
June 22, 2015
315755
NCT00003287
Completed
Completed
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Intervention: FOLFOX Regimen, Fluorouracil, Leucovorin Calcium, Oxaliplatin
Conditions: Colorectal Cancer
Intervention: FOLFOX Regimen, Fluorouracil, Leucovorin Calcium, Oxaliplatin
June 29, 2012
315756
NCT00076427
Completed
Completed
Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C; HIV Infections
Conditions: Hepatitis C; HIV Infections
October 5, 2017
315757
NCT00076414
Completed
Completed
The Effect of Lopinavir/Ritonavir on Endothelial Function
Conditions: Healthy
Intervention: Acetylcholine, L-NMMA
Conditions: Healthy
Intervention: Acetylcholine, L-NMMA
March 3, 2008
315758
NCT00076349
Completed
Completed
SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
Conditions: Non-Hodgkin's Lymphoma
Intervention: Bendamustine And Rituximab
Conditions: Non-Hodgkin's Lymphoma
Intervention: Bendamustine And Rituximab
May 8, 2014
315759
NCT00076336
Completed
Completed
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
Conditions: Hepatitis; Hepatitis B, Chronic; Cirrhosis
Intervention: Telbivudine, Lamivudine, Placebo
Conditions: Hepatitis; Hepatitis B, Chronic; Cirrhosis
Intervention: Telbivudine, Lamivudine, Placebo
August 4, 2011
315760
NCT00003137
Completed
Completed
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
Conditions: Esophageal Cancer; Gastric Cancer
Intervention: Irinotecan Hydrochloride
Conditions: Esophageal Cancer; Gastric Cancer
Intervention: Irinotecan Hydrochloride
July 12, 2016
315761
NCT00003007
Completed
Completed
Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Recombinant Interferon Alfa, Sargramostim, Cyclophosphamide, Dexamethasone, Melphalan, Peripheral Blood Stem Cell Transplantation
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Recombinant Interferon Alfa, Sargramostim, Cyclophosphamide, Dexamethasone, Melphalan, Peripheral Blood Stem Cell Transplantation
June 25, 2013
315762
NCT00002840
Completed
Completed
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Conditions: Brain and Central Nervous System Tumors
Intervention: Lomustine, Procarbazine Hydrochloride, Vincristine Sulfate, Radiation Therapy
Conditions: Brain and Central Nervous System Tumors
Intervention: Lomustine, Procarbazine Hydrochloride, Vincristine Sulfate, Radiation Therapy
July 6, 2012
315763
NCT00002817
Unknown status
Unknown status
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Conditions: Melanoma (Skin)
Intervention: Sargramostim, Vaccinia-GM-CSF Vaccine
Conditions: Melanoma (Skin)
Intervention: Sargramostim, Vaccinia-GM-CSF Vaccine
January 9, 2014
315764
NCT00002748
Completed
Completed
Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
Conditions: Neuroblastoma
Intervention: Gene-modified Tumor Cell Vaccine Therapy, Interleukin-2 Gene
Conditions: Neuroblastoma
Intervention: Gene-modified Tumor Cell Vaccine Therapy, Interleukin-2 Gene
October 3, 2011
315765
NCT00076323
Completed
Completed
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency; Favism
Intervention: Primaquine
Conditions: Glucosephosphate Dehydrogenase Deficiency; Favism
Intervention: Primaquine
July 26, 2010
315766
NCT00076310
Active, not recruiting
Active, not recruiting
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
Conditions: Head and Neck Cancer
Intervention: Docetaxel, OSI-774, Cisplatin
Conditions: Head and Neck Cancer
Intervention: Docetaxel, OSI-774, Cisplatin
April 26, 2018
315767
NCT00076284
Completed
Completed
March 3, 2008
315768
NCT00076271
Completed
Completed
Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases
Conditions: Eye Diseases
Conditions: Eye Diseases
June 30, 2017
315769
NCT00076258
Completed
Completed
Adding Exercise to Antidepressant Medication Treatment for Depression
Conditions: Depression
Intervention: SSRI + LD, SSRI + PHD
Conditions: Depression
Intervention: SSRI + LD, SSRI + PHD
October 14, 2016
315770
NCT00076245
Completed
Completed
Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD)
Conditions: Seasonal Affective Disorder; Depression
Intervention: Light Therapy, Cognitive Behavioral Therapy (CBT)
Conditions: Seasonal Affective Disorder; Depression
Intervention: Light Therapy, Cognitive Behavioral Therapy (CBT)
June 24, 2014
315771
NCT00076219
Completed
Completed
Acute Renal Failure Trial Network (ATN) Study
Conditions: Acute Renal Failure
Intervention: Renal Replacement Therapy
Conditions: Acute Renal Failure
Intervention: Renal Replacement Therapy
August 16, 2013
315772
NCT00076206
Terminated
Terminated
Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
Conditions: Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
December 7, 2015
315773
NCT00076232
Completed
Completed
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
Conditions: HIV Infections; HIV Seronegativity; Herpes Genitalis
Intervention: Acyclovir, Acyclovir Placebo
Conditions: HIV Infections; HIV Seronegativity; Herpes Genitalis
Intervention: Acyclovir, Acyclovir Placebo
December 29, 2010
315774
NCT00076154
Completed
Completed
April 18, 2014
315775
NCT00076141
Active, not recruiting
Active, not recruiting
Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop
Conditions: Healthy
Conditions: Healthy
September 12, 2019
315776
NCT00076115
Completed
Completed
Study to Determine the Effectiveness of Risperidone in Bipolar Disorder in Children and Adolescents
Conditions: Bipolar Disorder
Intervention: Risperidone
Conditions: Bipolar Disorder
Intervention: Risperidone
June 6, 2011
315777
NCT00076180
Completed
Completed
Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia
Conditions: T-Cell Large Granular Lymphocytic Leukemia; Leukemia, T-Cell Large Granular Lymphocytic
Intervention: Hu-MiK-Beta-1
Conditions: T-Cell Large Granular Lymphocytic Leukemia; Leukemia, T-Cell Large Granular Lymphocytic
Intervention: Hu-MiK-Beta-1
January 10, 2019
315778
NCT00076089
Completed
Completed
OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)
Conditions: Chronic Obstructive Pulmonary Disease; COPD
Intervention: Roflumilast
Conditions: Chronic Obstructive Pulmonary Disease; COPD
Intervention: Roflumilast
December 1, 2016
315779
NCT00076076
Completed
Completed
The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
Conditions: Asthma
Intervention: Roflumilast
Conditions: Asthma
Intervention: Roflumilast
December 1, 2016
315780
NCT00033735
Completed
Completed
Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
Conditions: Pancreatic Cancer
Intervention: Fluorouracil, Irofulven
Conditions: Pancreatic Cancer
Intervention: Fluorouracil, Irofulven
December 20, 2012
315781
NCT00027508
Terminated
Terminated
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma
Intervention: Trabectedin
Conditions: Malignant Mesothelioma
Intervention: Trabectedin
February 23, 2015
315782
NCT00024401
Unknown status
Unknown status
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Intervention: DHA-paclitaxel
Conditions: Colorectal Cancer
Intervention: DHA-paclitaxel
July 23, 2008
315783
NCT00002566
Unknown status
Unknown status
Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor; Testicular Germ Cell Tumor
Intervention: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Ifosfamide, Vinblastine Sulfate, Autologous Bone Marrow Transplantation, Conventional Surgery, Peripheral Blood Stem Cell Transplantation
Conditions: Extragonadal Germ Cell Tumor; Testicular Germ Cell Tumor
Intervention: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Ifosfamide, Vinblastine Sulfate, Autologous Bone Marrow Transplantation, Conventional Surgery, Peripheral Blood Stem Cell Transplantation
November 2, 2010
315784
NCT00076102
Completed
Completed
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis 1; Neurofibroma, Plexiform
Intervention: Pirfenidone
Conditions: Neurofibromatosis 1; Neurofibroma, Plexiform
Intervention: Pirfenidone
April 19, 2018
315785
NCT00076063
Completed
Completed
A Study of LIPO-5 and ALVAC-HIV (vCP1452) as Possible HIV Vaccines
Conditions: HIV Infections
Intervention: ALVAC-HIV (vCP1452), LIPO-5
Conditions: HIV Infections
Intervention: ALVAC-HIV (vCP1452), LIPO-5
March 12, 2015
315786
NCT00076050
Completed
Completed
Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms
Conditions: Menopause; Osteoporosis; Osteopenia
Intervention: Soy Isoflavones, Placebo
Conditions: Menopause; Osteoporosis; Osteopenia
Intervention: Soy Isoflavones, Placebo
October 12, 2016
315787
NCT00076037
Completed
Completed
Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
Conditions: HIV Infections
Intervention: HIV CTL MEP Administered With RC529-SE Adjuvant, GM-CSF
Conditions: HIV Infections
Intervention: HIV CTL MEP Administered With RC529-SE Adjuvant, GM-CSF
March 3, 2015
315788
NCT00076024
Completed
Completed
AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer
Conditions: Breast Neoplasms
Intervention: Placebo, Docetaxel, AG-013736 (axitinib), Docetaxel
Conditions: Breast Neoplasms
Intervention: Placebo, Docetaxel, AG-013736 (axitinib), Docetaxel
June 21, 2012
315789
NCT00076011
Completed
Completed
Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma
Conditions: Kidney Neoplasms
Intervention: Vascular Endothelial Growth Factor Receptor [VEGFR] And Platelet-Derived Growth Factor Receptor [PDGFR] Inhibitor
Conditions: Kidney Neoplasms
Intervention: Vascular Endothelial Growth Factor Receptor [VEGFR] And Platelet-Derived Growth Factor Receptor [PDGFR] Inhibitor
June 20, 2012
315790
NCT00075998
Terminated
Terminated
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis; Lung Disease; Pulmonary Fibrosis
Intervention: Interferon Gamma-1b ("Actimmune")
Conditions: Idiopathic Pulmonary Fibrosis; Lung Disease; Pulmonary Fibrosis
Intervention: Interferon Gamma-1b ("Actimmune")
July 1, 2009
315791
NCT00075985
Completed
Completed
Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist
Conditions: Atrial Fibrillation
Conditions: Atrial Fibrillation
January 20, 2009
315792
NCT00075972
Completed
Completed
Mood and Smoking: A Comparison of Smoking Cessation Treatments
Conditions: Smoking Cessation; Mood Tolerance; Mood Management; Nicotine Replacement Therapy
Intervention: Mood Tolearance, Mood Management, Nicotine Replacement Therapy
Conditions: Smoking Cessation; Mood Tolerance; Mood Management; Nicotine Replacement Therapy
Intervention: Mood Tolearance, Mood Management, Nicotine Replacement Therapy
June 25, 2015
315793
NCT00075959
Completed
Completed
Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
Conditions: Intracerebral Hemorrhage
Intervention: NXY-059
Conditions: Intracerebral Hemorrhage
Intervention: NXY-059
January 3, 2013
315794
NCT00075946
Active, not recruiting
Active, not recruiting
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Intervention: Rituximab
Conditions: Lymphoma
Intervention: Rituximab
December 30, 2018
315795
NCT00024388
Unknown status
Unknown status
Chemotherapy in Treating Patients With Metastatic Kidney Cancer
Conditions: Kidney Cancer
Intervention: DHA-paclitaxel
Conditions: Kidney Cancer
Intervention: DHA-paclitaxel
July 23, 2008
315796
NCT00022347
Completed
Completed
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Intervention: Canfosfamide Hydrochloride
Conditions: Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
Intervention: Canfosfamide Hydrochloride
June 25, 2013
315797
NCT00022321
Unknown status
Unknown status
Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes
Intervention: Gemtuzumab Ozogamicin
Conditions: Myelodysplastic Syndromes
Intervention: Gemtuzumab Ozogamicin
December 18, 2013
315798
NCT00021333
Completed
Completed
Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
Conditions: Head and Neck Cancer; Lung Cancer
Intervention: Filgrastim, Cisplatin, Paclitaxel, Radiation Therapy
Conditions: Head and Neck Cancer; Lung Cancer
Intervention: Filgrastim, Cisplatin, Paclitaxel, Radiation Therapy
April 16, 2013
315799
NCT00021307
Withdrawn
Withdrawn
Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Intervention: Carboplatin, Temozolomide
Conditions: Brain and Central Nervous System Tumors
Intervention: Carboplatin, Temozolomide
July 10, 2013
315800
NCT00075933
Completed
Completed
April 27, 2009
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6296 6297 6298 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 6322 6323 6324 6325 6326 6327 6328 6329 6330 6331 6332 6333 6334 6335 6336 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.